Form 4 · Filed May 19, 2026, 10:06 PM UTC
PCSA/Processa Pharmaceuticals, Inc.
Ng George K — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 15, 2026 | P | buy | 1,843 | $3 | $5,474 | 7,841 |
Source: SEC EDGAR raw filing ↗ · Accession 0000897069-26-001186